Retraction: Emerging roles and underlying molecular mechanisms of DNAJB6 in cancer

Erhong Meng; Lalita A. Shevde; Rajeev S. Samant

doi:10.18632/oncotarget.28439

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Retraction:

Retraction: Emerging roles and underlying molecular mechanisms of DNAJB6 in cancer

PDF | How to cite

Oncotarget. 2023; 14:669-669. https://doi.org/10.18632/oncotarget.28439

Metrics: PDF 489 views | ?

Erhong Meng^1,3, Lalita A. Shevde^1,2 and Rajeev S. Samant^1,2

¹Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA
²Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama, USA
³Beijing DOING Biomedical Technology Co. Ltd., Beijing, China

Published: July 01, 2023

Copyright: © 2023 Meng et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been retracted: While re-examining this review article published in Oncotarget in 2016, it came to the authors’ attention that significant portions of the text were borrowed verbatim from other publications. Although the borrowed text was properly cited, the authors have concluded that the text in multiple places was not adequately paraphrased or appropriately quoted. In light of this, all authors have agreed to the retraction of this article from Oncotarget.

Original article: Oncotarget. 2016; 7:53984–53996. DOI: https://doi.org/10.18632/oncotarget.9803

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28439

Publication Alerts

Post-Publication Promotion

Publication Discount

Retraction:

Retraction: Emerging roles and underlying molecular mechanisms of DNAJB6 in cancer